1988
DOI: 10.1002/ijc.2910420305
|View full text |Cite
|
Sign up to set email alerts
|

Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinoma

Abstract: Expression of the Epstein-Barr virus (EBV) encoded nuclear antigens (EBNA 1 to 6) and membrane-associated protein (LMP) was investigated by immunoblotting in 83 nasopharyngeal carcinoma (NPC) biopsies and 25 other tumor and normal tissue specimens from the head and neck region. Fifty-eight of the 83 NPC biopsies were large enough to yield parallel data on virus DNA and viral expression. All 16 cases of clinically diagnosed and histologically confirmed NPCs from North Africa contained EBV DNA and expressed EBNA… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

6
250
0
2

Year Published

1996
1996
2004
2004

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 417 publications
(258 citation statements)
references
References 53 publications
6
250
0
2
Order By: Relevance
“…Only two virally encoded proteins, the EBV-encoded nuclear antigen 1 (EBNA1) and the latent membrane protein 1 (LMP1), have been detected in NPC biopsies by Western blot analysis. 2 Biologically, EBNA1 is an EBV-encoded transactivator and is required in trans to maintain the virus genome in an episomal form. 3 LMP1 is an integral membrane protein and has a profound effect on the morphology of rodent cells, indicating that the protein is potentially oncogenic.…”
Section: Introductionmentioning
confidence: 99%
“…Only two virally encoded proteins, the EBV-encoded nuclear antigen 1 (EBNA1) and the latent membrane protein 1 (LMP1), have been detected in NPC biopsies by Western blot analysis. 2 Biologically, EBNA1 is an EBV-encoded transactivator and is required in trans to maintain the virus genome in an episomal form. 3 LMP1 is an integral membrane protein and has a profound effect on the morphology of rodent cells, indicating that the protein is potentially oncogenic.…”
Section: Introductionmentioning
confidence: 99%
“…Since no suitable system has so far been developed for infecting epithelial cells with EBV, no direct evidence has yet been reported on EBV ability to immortalize epithelial cells. While EBNA 2 is a key element of B cell growth transformation (Cohen et al, 1989), its expression was not detected in NPC biopsies or NPC derived epithelial cells (Fahraeus et al, 1988;Hitt et al, 1989;Young et al, 1988). By contrast, three latent genes: EBNA1, LMP1 and LMP2, were shown to be transcribed in NPC biopsies (Fahraeus et al, 1988;Hitt et al, 1989;Young et al, 1988;Brooks et al, 1992;Busson et al, 1992).…”
Section: Introductionmentioning
confidence: 99%
“…While EBNA 2 is a key element of B cell growth transformation (Cohen et al, 1989), its expression was not detected in NPC biopsies or NPC derived epithelial cells (Fahraeus et al, 1988;Hitt et al, 1989;Young et al, 1988). By contrast, three latent genes: EBNA1, LMP1 and LMP2, were shown to be transcribed in NPC biopsies (Fahraeus et al, 1988;Hitt et al, 1989;Young et al, 1988;Brooks et al, 1992;Busson et al, 1992). LMP1 may be important in NPC development since this latent gene, ®rst found to induce malignant transformation in established rodent ®broblasts (Wang et al, 1985;Baichwal and Sugden, 1988), was recently shown to inhibit di erentiation (Dawson et al, 1990) and cause morphological change with reduced cytokeratin expression in human epithelial cells (Fahraeus et al, 1990;Niedobitek et al, 1992).…”
Section: Introductionmentioning
confidence: 99%
“…2 The type II latency pattern was first seen in EBV carrying nasopharyngeal carcinoma (NPC). 10 In addition to HL, it occurs also in T and NK lymphomas. In Burkitt lymphomas (BLs) and in the EBV-carrying memory B cells of healthy individuals, only one viral protein, EBNA-1, is expressed.…”
mentioning
confidence: 99%